<DOC>
	<DOC>NCT00404313</DOC>
	<brief_summary>A clinical study to evaluate the efficacy and safety of MK0633 in adult patients with chronic asthma.</brief_summary>
	<brief_title>The Effect of MK0633 in Patients With Chronic Asthma (0633-007)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Documented clinical history of symptoms of chronic asthma, including dyspnea, wheezing, chest tightness, cough, and/or sputum production Males and females 1870 years of age History of kidney or chronic liver disease Recent history of heart problems within the past 3 months Evidence of another clinically significant, active lung disorder such as bronchiectasis or COPD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>